U.S. poised to switch COVID-19 prevention strategy to annual vaccine
The U.S. Food and Drug Administration said Monday it was weighing a shift in its COVID-19 strategy to an annual vaccine program similar to that employed against flu.
The U.S. Food and Drug Administration said Monday it was weighing a shift in its COVID-19 strategy to an annual vaccine program similar to that employed against flu.